U.S. Physical Therapy (USPH) Stock Forecast & Price Target

$98.32

+1.32 (+1.36%)

(As of 07/26/2024 ET)

U.S. Physical Therapy - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 3 Analyst Ratings

Based on 3 Wall Street analysts who have issued ratings for U.S. Physical Therapy in the last 12 months, the stock has a consensus rating of "Buy." Out of the 3 analysts, 3 have given a buy rating for USPH.

Consensus Price Target

$119.50
21.54% Upside

High Forecast	$122.00
Average Forecast	$119.50
Low Forecast	$117.00

According to the 3 analysts' twelve-month price targets for U.S. Physical Therapy, the average price target is $119.50. The highest price target for USPH is $122.00, while the lowest price target for USPH is $117.00. The average price target represents a forecasted upside of 21.54% from the current price of $98.32.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	2 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$119.50	$125.67	$125.67	$127.00
Forecasted Upside	21.54% Upside	14.46% Upside	13.96% Upside	14.79% Upside

Get U.S. Physical Therapy Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for USPH and its competitors with MarketBeat's FREE daily newsletter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

USPH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

USPH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

U.S. Physical Therapy Stock vs. The Competition

Type	U.S. Physical Therapy	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.72	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	21.54% Upside	3,121.53% Upside	9.09% Upside
News Sentiment Rating	Negative News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
5/9/2024	Barrington Research 4 of 5 stars	Reiterated Rating	Outperform ➝ Outperform	$122.00 ➝ $122.00	+16.76%
3/13/2024	JPMorgan Chase & Co. 3 of 5 stars	Boost Target	Overweight ➝ Overweight	$99.00 ➝ $117.00	+8.65%
9/19/2023	CJS Securities 5 of 5 stars	Upgrade	Market Perform ➝ Outperform
6/30/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$138.00	+17.76%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:51 AM ET.

USPH Forecast - Frequently Asked Questions

What is U.S. Physical Therapy's forecast for 2024?: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for U.S. Physical Therapy is $119.50, with a high forecast of $122.00 and a low forecast of $117.00.
Should I buy or sell U.S. Physical Therapy stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" USPH shares.
Does U.S. Physical Therapy's stock price have much upside?: According to analysts, U.S. Physical Therapy's stock has a predicted upside of 12.64% based on their 12-month stock forecasts.
What analysts cover U.S. Physical Therapy?: U.S. Physical Therapy has been rated by research analysts at Barrington Research in the past 90 days.
Do Wall Street analysts like U.S. Physical Therapy more than its competitors?: Analysts like U.S. Physical Therapy more than other "medical" companies. The consensus rating for U.S. Physical Therapy is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how USPH compares to other companies.